Florida Telehealth Laws: Registration, Prescribing, Consent

Florida runs the most open front door on the East Coast — a free registration that lets out-of-state providers treat Florida patients without a Florida license — and one of the least regulated payment environments, with no parity mandate at all. It's a state built for telehealth supply, not for telehealth reimbursement guarantees. Since 2024, it's also an Interstate Medical Licensure Compact member, which surprises people who learned the map a few years ago.

Licensure: the registration is the story

Florida's default rule matches everyone else's — care is delivered where the patient is located, and treating Florida patients requires Florida authorization. What's different is the second pathway. Under § 456.47(4), a practitioner with an active, unencumbered license in another state that is substantially similar to the Florida license, with no disciplinary action in the preceding five years and no pending disciplinary investigation or revoked license anywhere, can register as an out-of-state telehealth provider instead of getting licensed. According to the Department of Health's registration FAQ, there is no fee to apply or register and the registration does not expire. It covers a long list of professions: physicians, NPs, psychologists, clinical social workers, mental health counselors, PTs, dentists, and dozens more.

The trade-offs are structural: registrants may not open an office in Florida or provide in-person care in the state, must designate a Florida registered agent, must carry liability coverage or financial responsibility at Florida levels, must prominently link to the Department of Health's registrant page from their website, and must report any license restriction or disciplinary action to the board within five business days (§ 456.47(4)(c)–(f)). It's a telehealth-only lane by design — and for a virtual-first practice serving snowbirds or Florida's enormous retiree population, it removes most of the licensure friction that defines states like New York.

Since 2024, Florida has also been an IMLC member (many directories haven't caught up), so full licensure via the compact is available when a practice needs an in-person footprint too. Beyond registration, the statute exempts emergency care and consultations where a Florida-licensed professional retains authority over the patient. Florida is also a Nurse Licensure Compact state and a PSYPACT participating state; it has joined the Counseling Compact but is not yet issuing privileges, and it is not a Physical Therapy Compact member.

Prescribing: telehealth evaluation suffices — except Schedule II

Florida is explicit that a telehealth evaluation alone can establish the treatment relationship; no prior in-person exam or record review is required before evaluating, diagnosing, and treating remotely.

The controlled-substance line sits at Schedule II. Telehealth providers may not prescribe Schedule II substances via telehealth except for psychiatric disorders, hospital inpatients, hospice patients, and nursing home residents. The psychiatric exception is what keeps telepsychiatry — including stimulant prescribing — viable in Florida, and the state restriction governs regardless of what federal rules allow. Schedules III–V carry no Florida-specific telehealth restriction. Section 456.47(2)(f) also bars using telehealth to perform an abortion, including medication abortion. Medical marijuana has its own rule: recertifications can happen by telehealth, but the initial exam must be in person.

Other state duties apply to telehealth exactly as they do in person:

• Registration. Florida has no separate state controlled substance registration. Its controlled substances chapter defines a "practitioner" as a professional licensed under a listed Florida licensing chapter who holds a valid federal controlled substance registry number (§ 893.02(23)), although the same chapter also treats an order from a practitioner licensed in another state as a prescription if the Florida pharmacist judges it valid (§ 893.02(24)(a)); registrants should confirm with their board and counsel how this applies to controlled-substance prescribing. Prescribers of Schedule II–IV drugs for chronic nonmalignant pain must designate themselves as controlled substance prescribing practitioners on their practitioner profile (§ 456.44(2)).
• PDMP. A prescriber or designee must consult E-FORCSE, the state prescription drug monitoring database, before prescribing any controlled substance to a patient 16 or older, except nonopioid Schedule V drugs and patients admitted to hospice. If the system is down, the prescriber documents why it was not consulted and may prescribe no more than a 3-day supply (§ 893.055(8)).
• Opioid limits. For acute pain, a Schedule II opioid prescription may not exceed a 3-day supply, or up to a 7-day supply if the prescriber judges more medically necessary, writes "ACUTE PAIN EXCEPTION" on the prescription, and documents the reasons. Schedule II opioid prescriptions for other pain must be marked "NONACUTE PAIN." Pain related to cancer, a terminal condition, palliative care, or a traumatic injury with an Injury Severity Score of 9 or greater is not "acute pain" under the statute (§ 456.44(1), (5)). Schedule II prescribing for pain from a traumatic injury with an Injury Severity Score of 9 or greater requires a concurrent prescription for an emergency opioid antagonist (§ 456.44(6)). Before prescribing a Schedule II opioid for pain, outside a hospital critical care unit, emergency department, or hospice, the prescriber must inform the patient of nonopioid alternatives, discuss their advantages and disadvantages, provide the Department of Health's pamphlet, and document it (§ 456.44(7)).
• E-prescribing. A prescriber who maintains an electronic health record system, or who prescribes as an owner, employee, or contractor of a facility or practice that maintains one, may only transmit prescriptions electronically, for all medicinal drugs. Exceptions include a prescriber who is also the dispenser, prescriptions the e-prescribing standard cannot carry, Department of Health waivers of up to one year, delays that would harm the patient, and hospice or nursing home patients (§ 456.42(3)). Medicare Part D separately requires at least 70 percent of Part D Schedule II–V prescriptions to be electronic under 42 CFR 423.160, subject to exceptions and waivers.

Federal law adds a separate layer for controlled substances. Under the temporary rule DEA and HHS published December 31, 2025 (90 FR 61301), which runs through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter without a prior in-person evaluation, when the rule's other conditions are met; audio-only encounters qualify only for Schedule III–V narcotic medications approved by the FDA to treat opioid use disorder. Florida's Schedule II rule applies on top of that federal rule; our DEA prescribing report tracks the federal side.

Consent: no telehealth-specific mandate

Florida has no telehealth consent statute — § 456.47 simply doesn't address it, and neither the Medicaid program nor private-payer law imposes one. General informed-consent obligations and professional standards still apply, and documenting consent remains good practice, but there's no Florida-specific form or signature requirement to build into intake the way there is in New Jersey.

Medicaid: covered, but no audio-only

Florida Medicaid covers live video (billed with the GT modifier), store-and-forward, and remote patient monitoring — the RPM coverage includes high-risk pregnancy programs. The notable gap: audio-only is not covered. The COVID-era telephone flexibility ended in 2023, and the rule explicitly excludes telephone, email, and fax. For populations with limited video access, that's a real constraint on program design. The rule doesn't restrict originating sites, and managed-care plans can and do cover more than the base rule requires — check plan-specific policies.

Private insurance: no parity, by choice

Florida is one of the states that deliberately declined a parity mandate. Section 627.42396, and its HMO counterpart in § 641.31(45), require only that insurer-provider telehealth contracts be voluntary, with "mutually acceptable payment rates" — and any contract term that pays telehealth differently from in-person care must be initialed by the provider. Neither statute sets a coverage mandate, a cost-sharing rule, an in-network limit, a utilization review standard, or an audio-only rule. The current § 456.47 definition of telehealth excludes only email and fax, so audio-only calls count as telehealth for practice purposes, but that definition does not set what plans must pay for. That initialing requirement is the statute's one protective gesture: nobody should discover a telehealth discount they didn't knowingly agree to. Practically, telehealth economics in Florida are whatever you negotiate. Model revenue from your actual contracts, not from assumptions that travel from parity states — the broader picture is in our reimbursement guide.

What to watch

Florida's framework has been stable since its last substantive amendments in 2023, and a 2026 proposal to add naturopathic doctors to the provider definition did not pass. The bigger variables are federal: the DEA's pending special-registration rule will shape what the psychiatric Schedule II exception is worth, and any Medicare changes flow through heavily in a state this Medicare-dense. Verify current requirements with the Board of Medicine and AHCA before acting — and compare Florida's approach with the rest of the coast in the national overview.